Interviews with political figures and news updates. Interviews with political figures and news updates. Able to sell the shares. They have telephone logs, who called whom and when. It appears they have people helping the government out with the testimony. As mimi said, andrea, its kind of overwhelming evidence thats difficult for federal prosecutors to ignore. And chuck todd, weve not yet seen to my knowledge a tweet from the president or any suggestion that this is witch hunt, mueller related. But this is really separate, this is an investigation that started, there was an Ethics Investigation that we heard about some months back, last year sometime. And so this does not come from the Mueller Operation at all. Right. And thats the thing, it has zero to do this is just bad timing, bad coincidence. And it looks bad, right . Here is yet another person close to the president who seems to be taking advantage of access,
special access, or a pay to play issue. The president s ally, the presi
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2023 Earnings Call Transcript November 14, 2023 Acurx Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.23952, expectations were $-0.28. Operator: Ladies and gentlemen, good morning, and welcome to the Acurx Pharmaceuticals Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief […]
The orphan drug designation was granted based on data from the randomized Phase II clinical trial NIPU The results from the NIPU study will be presented at the ESMO Congress being held October 20-24, 2023 in MadridUV1 also received FDA orphan drug designation for treatment of patients with malignant melanoma in December 2021 Oslo, October 09, 2023: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, today announced that the